Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human insulin-like growth factor-1 / recombinant human insulin-like growth factor binding protein-3

IGF-1/IGFBP-3 · Insmed Incorporated
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human insulin-like growth factor-1 / recombinant human insulin-like growth factor binding protein-3, covering 2007-03-30 to 2007-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome [Phase 2]

See pricing